G20
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 40 and 75. Signing of informed consent. Only subjects with previous nuclear medicine examination: V.a. a parkinsonian syndrome (which led to referral to nuclear medicine for FP-CIT SPECT examination).
Exclusion criteria
Exclusion criteria: Non-consent or inability of the subject to consent to study participation; pre-existing high-dose symptomatic dopaminergic therapy (> 600 mg levodopa equivalent dose); relevant postural disorder (regular falls, propensity to fall in the so-called pull test); alcohol/drug abuse (current or history); depression (BDI > 19 points); acute psychotic symptomatology; severe previous internal disease (e.g., heart failure. e.g., heart failure) or orthopedic/rheumatologic pre-existing conditions that interfere with expenditure performance; inability to perform the experimental tasks; pregnancy; relevant daytime sleepiness (ESS >12), relevant cognitive impairment (MOCA score < 18).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extent of motor learning in patients with Parkinson's disease compared to healthy controls. | — |
Secondary
| Measure | Time frame |
|---|---|
| Extent of learning success dependent on dopaminergic deficit in DaTScan in patients with parkinson disease. | — |
Countries
Germany
Contacts
Neurologie Uniklinik Leipzig